Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gynecologic 3Head & Neck 2Gastrointestinal 2Breast 2CNS 1

Conditions

Glioblastoma 108Brain Neoplasms 106Glioma 83Neuroblastoma 34Astrocytoma 26Neoplasms 25Medulloblastoma 25Central Nervous System Neoplasms 25Neurofibromatosis 1 23Meningioma 23Ependymoma 22Sarcoma 21Breast Neoplasms 18Rhabdoid Tumor 16Melanoma 16Neurofibroma, Plexiform 15Carcinoma, Non-Small-Cell Lung 15Osteosarcoma 14Wilms Tumor 13Rhabdomyosarcoma 13Thyroid Neoplasms 12Sarcoma, Ewing 12Hepatoblastoma 12Gliosarcoma 12Recurrence 11Diffuse Intrinsic Pontine Glioma 11Pheochromocytoma 10Pancreatic Neoplasms 10Neoplasm Metastasis 10Ovarian Neoplasms 9

Interventions

lorlatinib 1encorafenib 1binimetinib 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × CNS × 30 days × Clear all
NCT04800822 2026-06-04

PF-07284892 in Participants With Advanced Solid Tumors

Pfizer

Phase 1 Terminated
53 enrolled
CNSGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neurofibromatosis 1, Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡